Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)

Rani Therapeutics Holdings has reported Return on Invested Capital over the past 3 years, most recently at 1.99% for Q4 2023.

  • Quarterly results put Return on Invested Capital at 1.99% for Q4 2023, down 120.0% from a year ago — trailing twelve months through Dec 2023 was 1.99% (down 120.0% YoY), and the annual figure for FY2022 was 0.65%, up 998.0%.
  • Return on Invested Capital for Q4 2023 was 1.99% at Rani Therapeutics Holdings, down from 1.66% in the prior quarter.
  • Over the last five years, Return on Invested Capital for RANI hit a ceiling of 0.15% in Q2 2021 and a floor of 9.4% in Q3 2021.
  • Median Return on Invested Capital over the past 3 years was 0.68% (2022), compared with a mean of 1.55%.
  • Biggest five-year swings in Return on Invested Capital: skyrocketed 876bps in 2022 and later tumbled -120bps in 2023.
  • Rani Therapeutics Holdings' Return on Invested Capital stood at 0.41% in 2021, then plummeted by -94bps to 0.79% in 2022, then crashed by -152bps to 1.99% in 2023.
  • The last three reported values for Return on Invested Capital were 1.99% (Q4 2023), 1.66% (Q3 2023), and 1.25% (Q2 2023) per Business Quant data.